生命科学资讯

Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to home

FDA slams ExThera with warning letter over controversial blood filter device

Ginkgo divests biosecurity arm; J&J's early prostate cancer data

Padcev-Keytruda combo delivers more positive data in bladder cancer

Is It Time To Reassess 10x Genomics (TXG) After Its 105% One Year Surge - simplywall.st

Novartis closes Avidity deal as rare heart disease spinout launches

Omics in Orlando Day 2: A Video Report from AGBT - GEN - Genetic Engineering and Biotechnology News

Florida lab uses genome sequencing to diagnose children with rare diseases - Stock Titan

Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - Yahoo Finance

Investors are pumping money into AI tools for health insurers

Waters Corporation $WAT Holdings Cut by Westpac Banking Corp - MarketBeat

Handelsbanken Fonder AB Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Pivot Therapeutics develops new AKT1 inhibitors

MRGPRX2 antagonists disclosed in Arcus Biosciences patent

CSPC Zhongqi Pharmaceutical Technology discovers EGFR PROTAC degraders

Prospect Therapeutics identifies new JAK1 and TYK2 inhibitors

How PBM reforms could push drugmakers into the pricing spotlight

Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the future

Generate scores largest biotech IPO since 2024 with $400M Nasdaq listing

Thermo Fisher unveils test to aid in dosing of antirejection drug